Miyawaki, H., Kioka, H., Sato, K., Kurashige, M., Ozawa, T., Shibayama, H., . . . Sakata, Y. (2019). Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis. Intern Med.
Citação norma ChicagoMiyawaki, Hiroshi, et al. "Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib On Pulmonary Hypertension and the Cardiac Function in a Patient With Myelofibrosis." Intern Med 2019.
Citação norma MLAMiyawaki, Hiroshi, et al. "Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib On Pulmonary Hypertension and the Cardiac Function in a Patient With Myelofibrosis." Intern Med 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.